|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bruix J and Llovet JM: Prognostic
prediction and treatment strategy in hepatocellular carcinoma.
Hepatology. 35:519–524. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aravalli RN, Steer CJ and Cressman EN:
Molecular mechanisms of hepatocellular carcinoma. Hepatology.
48:2047–2063. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van Belzen N, Dinjens WN, Eussen BH and
Bosman FT: Expression of differentiation-related genes in
colorectal cancer: Possible implications for prognosis. Histol
Histopathol. 13:1233–1242. 1998.PubMed/NCBI
|
|
5
|
Thierry-Mieg D and Thierry-Mieg J:
AceView: A comprehensive cDNA-supported gene and transcripts
annotation. Genome Biol. 7:(Suppl 1). S12.1–14. 2006. View Article : Google Scholar
|
|
6
|
van Belzen N, Dinjens WN, Diesveld MP,
Groen NA, van der Made AC, Nozawa Y, Vlietstra R, Trapman J and
Bosman FT: A novel gene which is up-regulated during colon
epithelial cell differentiation and down-regulated in colorectal
neoplasms. Lab Invest. 77:85–92. 1997.PubMed/NCBI
|
|
7
|
Zhou D, Salnikow K and Costa M: Cap43, a
novel gene specifically induced by Ni2+ compounds.
Cancer Res. 58:2182–2189. 1998.PubMed/NCBI
|
|
8
|
Sibold S, Roh V, Keogh A, Studer P, Tiffon
C, Angst E, Vorburger SA, Weimann R, Candinas D and Stroka D:
Hypoxia increases cytoplasmic expression of NDRG1, but is
insufficient for its membrane localization in human hepatocellular
carcinoma. FEBS Lett. 581:989–994. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Akiba J, Ogasawara S, Kawahara A, Nishida
N, Sanada S, Moriya F, Kuwano M, Nakashima O and Yano H: N-myc
downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein
invasion and intrahepatic metastasis in human hepatocellular
carcinoma. Oncol Rep. 20:1329–1335. 2008.PubMed/NCBI
|
|
10
|
Chua MS, Sun H, Cheung ST, Mason V,
Higgins J, Ross DT, Fan ST and So S: Overexpression of NDRG1 is an
indicator of poor prognosis in hepatocellular carcinoma. Mod
Pathol. 20:76–83. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kurdistani SK, Arizti P, Reimer CL, Sugrue
MM, Aaronson SA and Lee SW: Inhibition of tumor cell growth by
RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res.
58:4439–4444. 1998.PubMed/NCBI
|
|
12
|
Lee JC, Chung LC, Chen YJ, Feng TH and
Juang HH: N-myc downstream-regulated gene 1 downregulates cell
proliferation, invasiveness, and tumorigenesis in human oral
squamous cell carcinoma. Cancer Lett. 355:242–252. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim-Fuchs C, Winterhalder S, Winter A,
Malinka T, Born D, Schäfer S, Stroka D, Gloor B, Candinas D and
Angst E: The silencing of N-myc downstream-regulated gene-1 in an
orthotopic pancreatic cancer model leads to more aggressive tumor
growth and metastases. Dig Surg. 31:135–142. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hu ZY, Xie WB, Yang F, Xiao LW, Wang XY,
Chen SY and Li ZG: NDRG1 attenuates epithelial-mesenchymal
transition of nasopharyngeal cancer cells via blocking Smad2
signaling. Biochim Biophys Acta. 1852:1876–1886. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chang X, Xu X, Ma J, Xue X, Li Z, Deng P,
Zhang S, Zhi Y, Chen J and Dai D: NDRG1 expression is related to
the progression and prognosis of gastric cancer patients through
modulating proliferation, invasion and cell cycle of gastric cancer
cells. Mol Biol Rep. 41:6215–6223. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hosoya N, Sakumoto M, Nakamura Y, Narisawa
T, Bilim V, Motoyama T, Tomita Y and Kondo T: Proteomics identified
nuclear N-myc downstream-regulated gene 1 as a prognostic tissue
biomarker candidate in renal cell carcinoma. Biochim Biophys Acta.
1834:2630–2639. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Akiba J, Murakami Y, Noda M, Watari K,
Ogasawara S, Yoshida T, Kawahara A, Sanada S, Yasumoto M, Yamaguchi
R, et al: N-myc downstream regulated gene1/Cap43 overexpression
suppresses tumor growth by hepatic cancer cells through cell cycle
arrest at the G0/G1 phase. Cancer Lett. 310:25–34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng J, Xie HY, Xu X, Wu J, Wei X, Su R,
Zhang W, Lv Z, Zheng S and Zhou L: NDRG1 as a biomarker for
metastasis, recurrence and of poor prognosis in hepatocellular
carcinoma. Cancer Lett. 310:35–45. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan X, Chua MS, Sun H and So S: N-Myc
down-regulated gene 1 mediates proliferation, invasion, and
apoptosis of hepatocellular carcinoma cells. Cancer Lett.
262:133–142. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Desgrosellier JS and Cheresh DA: Integrins
in cancer: Biological implications and therapeutic opportunities.
Nat Rev Cancer. 10:9–22. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tadokoro S, Tomiyama Y, Honda S, Kashiwagi
H, Kosugi S, Shiraga M, Kiyoi T, Kurata Y and Matsuzawa Y: Missense
mutations in the beta(3) subunit have a different impact on the
expression and function between alpha(IIb)beta(3) and
alpha(v)beta(3). Blood. 99:931–938. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Varner JA and Cheresh DA: Tumor
angiogenesis and the role of vascular cell integrin alphavbeta3.
Important Adv Oncol. 69–87. 1996.PubMed/NCBI
|
|
23
|
Brooks PC, Strömblad S, Klemke R, Visscher
D, Sarkar FH and Cheresh DA: Antiintegrin alpha v beta 3 blocks
human breast cancer growth and angiogenesis in human skin. J Clin
Invest. 96:1815–1822. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Petitclerc E, Strömblad S, von Schalscha
TL, Mitjans F, Piulats J, Montgomery AM, Cheresh DA and Brooks PC:
Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin
by regulating tumor cell survival. Cancer Res. 59:2724–2730.
1999.PubMed/NCBI
|
|
25
|
Landen CN, Kim TJ, Lin YG, Merritt WM,
Kamat AA, Han LY, Spannuth WA, Nick AM, Jennnings NB, Kinch MS, et
al: Tumor-selective response to antibody-mediated targeting of
alphavbeta3 integrin in ovarian cancer. Neoplasia. 10:1259–1267.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kong Q, Wu G, Han L, Zhang Z, Du J, Sun W
and Cao L: A transfection method of PS-asODNs targeting ANGPTL4 in
multicellular structures of hepatocarcinoma cell line. Cancer Gene
Ther. 22:285–290. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Song Y, Lv L, Du J, Yue L and Cao L:
Correlation of N-myc downstream-regulated gene 1 subcellular
localization and lymph node metastases of colorectal neoplasms.
Biochem Biophys Res Commun. 439:241–246. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Homo sapiens N-myc downstream regulated 1
(NDRG1), transcript variant 3, mRNA. NCBI Reference Sequence:
NM_001258432.1. https://www.ncbi.nlm.nih.gov/nuccore/386643031
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cao L, Han L, Zhang Z, Li J, Qu Z, Du J,
Liang X, Liu Y, Liu H, Shi Y, et al: Involvement of
anoikis-resistance in the metastasis of hepatoma cells. Exp Cell
Res. 315:1148–1156. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Horton P, Park KJ, Obayashi T, Fujita N,
Harada H, Adams-Collier CJ and Nakai K: WoLF PSORT: Protein
localization predictor. Nucleic Acids Res. 35:(Web Server issue).
W585–W587. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bandyopadhyay S, Wang Y, Zhan R, Pai SK,
Watabe M, Iiizumi M, Furuta E, Mohinta S, Liu W, Hirota S, et al:
The tumor metastasis suppressor gene Drg-1 down-regulates the
expression of activating transcription factor 3 in prostate cancer.
Cancer Res. 66:11983–11990. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Inglis SK, Gallacher M, Brown SG, McTavish
N, Getty J, Husband EM, Murray JT and Wilson SM: SGK1 activity in
Na+ absorbing airway epithelial cells monitored by
assaying NDRG1-Thr346/356/366 phosphorylation. Pflugers Arch.
457:1287–1301. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hoang B, Frost P, Shi Y, Belanger E,
Benavides A, Pezeshkpour G, Cappia S, Guglielmelli T, Gera J and
Lichtenstein A: Targeting TORC2 in multiple myeloma with a new mTOR
kinase inhibitor. Blood. 116:4560–4568. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Murray JT, Campbell DG, Morrice N, Auld
GC, Shpiro N, Marquez R, Peggie M, Bain J, Bloomberg GB, Grahammer
F, et al: Exploitation of KESTREL to identify NDRG family members
as physiological substrates for SGK1 and GSK3. Biochem J.
384:477–488. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Segawa T, Nau ME, Xu LL, Chilukuri RN,
Makarem M, Zhang W, Petrovics G, Sesterhenn IA, McLeod DG, Moul JW,
et al: Androgen-induced expression of endoplasmic reticulum (ER)
stress response genes in prostate cancer cells. Oncogene.
21:8749–8758. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lachat P, Shaw P, Gebhard S, van Belzen N,
Chaubert P and Bosman FT: Expression of NDRG1, a
differentiation-related gene, in human tissues. Histochem Cell
Biol. 118:399–408. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sugiki T, Taketomi Y, Kikuchi-Yanoshita R,
Murakami M and Kudo I: Association of N-myc downregulated gene 1
with heat-shock cognate protein 70 in mast cells. Biol Pharm Bull.
27:628–633. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li Q and Chen H: Transcriptional silencing
of N-Myc downstream-regulated gene 1 (NDRG1) in metastatic colon
cancer cell line SW620. Clin Exp Metastasis. 28:127–135. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ma W, Na M, Tang C, Wang H and Lin Z:
Overexpression of N-myc downstream-regulated gene 1 inhibits human
glioma proliferation and invasion via phosphoinositide 3-kinase/AKT
pathways. Mol Med Rep. 12:1050–1058. 2015.PubMed/NCBI
|
|
42
|
Lu WJ, Chua MS, Wei W and So SK: NDRG1
promotes growth of hepatocellular carcinoma cells by directly
interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Oncotarget. 6:29847–29859. 2015.PubMed/NCBI
|
|
43
|
Lu WJ, Chua MS and So SK: Suppressing
N-Myc downstream regulated gene 1 reactivates senescence signaling
and inhibits tumor growth in hepatocellular carcinoma.
Carcinogenesis. 35:915–922. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chen Z, Zhang D, Yue F, Zheng M, Kovacevic
Z and Richardson DR: The iron chelators Dp44mT and DFO inhibit
TGF-β-induced epithelial-mesenchymal transition via up-regulation
of N-Myc downstream-regulated gene 1 (NDRG1). J Biol Chem.
287:17016–17028. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bandyopadhyay S, Pai SK, Gross SC, Hirota
S, Hosobe S, Miura K, Saito K, Commes T, Hayashi S, Watabe M and
Watabe K: The Drg-1 gene suppresses tumor metastasis in prostate
cancer. Cancer Res. 63:1731–1736. 2003.PubMed/NCBI
|
|
46
|
Sun J, Zhang D, Zheng Y, Zhao Q, Zheng M,
Kovacevic Z and Richardson DR: Targeting the metastasis suppressor,
NDRG1, using novel iron chelators: Regulation of stress
fiber-mediated tumor cell migration via modulation of the
ROCK1/pMLC2 signaling pathway. Mol Pharmacol. 83:454–469. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wangpu X, Lu J, Xi R, Yue F, Sahni S, Park
KC, Menezes S, Huang ML, Zheng M, Kovacevic Z and Richardson DR:
Targeting the metastasis suppressor, N-Myc downstream regulated
gene-1, with novel Di-2-pyridylketone thiosemicarbazones:
Suppression of tumor cell migration and cell-collagen adhesion by
inhibiting focal adhesion kinase/paxillin signaling. Mol Pharmacol.
89:521–540. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tang NH, Chen YL, Wang XQ, Li XJ, Wu Y,
Zou QL and Chen YZ: N-terminal and C-terminal heparin-binding
domain polypeptides derived from fibronectin reduce adhesion and
invasion of liver cancer cells. BMC Cancer. 10:5522010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Feng XX, Liu M, Yan W, Zhou ZZ, Xia YJ, Tu
W, Li PY and Tian DA: β3 integrin promotes
TGF-β1/H2O2/HOCl-mediated induction of metastatic phenotype of
hepatocellular carcinoma cells by enhancing TGF-β1 signaling. PLoS
One. 8:e798572013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Xu ZZ, Xiu P, Lv JW, Wang FH, Dong XF, Liu
F, Li T and Li J: Integrin alphavbeta3 is required for cathepsin
B-induced hepatocellular carcinoma progression. Mol Med Rep.
11:3499–3504. 2015.PubMed/NCBI
|
|
51
|
Weber MR, Zuka M, Lorger M, Tschan M,
Torbett BE, Zijlstra A, Quigley JP, Staflin K, Eliceiri BP, Krueger
JS, et al: Activated tumor cell integrin αβ3 cooperates with
platelets to promote extravasation and metastasis from the blood
stream. Thromb Res. 140:(Suppl 1). S27–S36. 2016. View Article : Google Scholar : PubMed/NCBI
|
